Key Drivers
- Margin expansion
- High leverage
- Weak profitability
AIAI Summary
ATEC has shifted from a pure “growth with losses” story to one where 15% revenue growth, improving margins, and positive free cash flow show real operating leverage, but the investment case remains fragile because high leverage, negative equity, dilution risk, and litigation overhang mean upside only matters if execution can compound faster than the balance-sheet drag.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin expansion
- •High leverage
- •Weak profitability
ATEC shows improving margins and EBITDA, but continued losses, high leverage, and weak cash conversion keep it a high-risk turnaround rather than a clear recovery.
Price Behavior
Key Price Behavior Insights:
- •Higher lows
- •Support holding
- •Momentum pause
ATEC's last month trend is constructive with higher lows and support around $9.20-$9.30, but momentum faded after the $10.35 high and a breakout above that resistance is needed to confirm further upside.
The price pulled back after the $10.35 high and traded in a wide range, signaling ongoing volatility risk
Sentiment & News
Key News Insights:
- •Revenue growth
- •Margin expansion
- •EPS miss
Alphatec delivered Q2 revenue growth of 15% to $214M with gross margins above 72% and positive free cash flow, but EPS of $0.07 missed estimates despite improved operating momentum.
The results suggest improving business quality and cash generation, but the earnings miss may temper near-term upside for the stock
Similar Companies in Healthcare
Other companies in the same sector with AI ratings